Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jun Wang, M.D.
Peking University People's Hospital
Study Chair - Kezhong Chen, M.D.
Peking University People's Hospital
Study Director - Yan Zhang, M.D.
The First Hospital of Shijiazhuang
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peking University People'S Hospital
Beijing, Beijing Municipality, China
Recruiting - Affiliated Hospital of Hebei University
Baoding, Hebei, China
Recruiting - Hebei Medical University Fourth Hospital
Shijiazhuang, Hebei, China
Recruiting - the First Hospital of Shijiazhuang
Shijiazhuang, Hebei, China
Recruiting - Xingtai People'S Hospital
Xingtai, Hebei, China
Recruiting - Handan Downtown Hospital
Handan, Heibe, China
Recruiting - Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Recruiting - Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Nov 2018
- Primary completion
- 1 May 2020
- Completion
- 1 Sept 2020
- Last update posted
- 13 Nov 2018
- Registered enrollment
- 120
- Registry id
- NCT03664843
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.